International variation in medication prescription rates among elderly patients with inflammatory bowel disease
International variation in medication prescription rates among elderly patients with inflammatory bowel disease
复制标题
DOI：
10.1016/j.crohns.2012.09.001
复制
发表时间：
2013-12-01
影响因子：
8
通讯作者：
Kappelman, Michael D.
中科院分区：
文献类型：
--
作者：
Benchimol, Eric I.;Cook, Suzanne F.;Kappelman, Michael D.
背景和目的：老年人是IBD患者中不断增长的人群。以前没有研究描述老年IBD患者的护理或药物处方的变化。我们比较了处方率与IBD的老年患者在四个国家使用卫生行政data.Methods：从美国（US），英国（UK），丹麦和加拿大的数据库进行查询。在2004年至2009年期间的某个季度内，对65岁的IBD流行患者中有1次IBD相关药物处方的国家间处方率差异进行了评估。使用先前报告的经验证的算法识别患者。结果：在克罗恩病患者中，加拿大和美国的口服5-阿萨处方率较高（P
Background and aims: The elderly represent a growing demographic of patients with IBD. No study has previously described variations in care or medication prescriptions in senior patients with IBD. We compared prescription rates among elderly patients with IBD in four countries using health administrative data.Methods: Databases from the United States (US), United Kingdom (UK), Denmark and Canada were queried. Variation in prescription rates between countries was assessed in patients 65 y with prevalent IBD who had 1 prescription for an IBD-related medication in a given quarter between 2004 and 2009. Patients were identified using previously-reported, validated algorithms. Country-specific rates were compared in each quarter using Fisher's exact test.Results: In patients with Crohn's disease, Canada and US had higher prescription rates for oral 5-ASA (P